Search

You searched for "entropion"

833 results found

All eyes on the future symposium hailed a great success

10 November 2025 | conference report, industry news, private sector
Leading providers in the eye healthcare sector, Optegra Eye Health Care and ZEISS, have successfully hosted their annual CPD-accredited symposium, ‘All Eyes on the Future’, bringing together experts from across the ophthalmic sector. The symposium welcomed 90 attendees, including optometrists,...

Introducing the Interest in Ophthalmology Association

15 December 2025 | education, training, foundation year, professional development, research
We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...

What's trending Dec/Jan 2019

1 December 2018 | | EYE - Orbit, EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
The Eye News Twelve Days of Christmas On the first day of Christmas, my true love gave to me…A #RyderCup globe injury An unfortunate spectator was hit in the eye by a wayward golf ball during the Ryder Cup, and...

Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk

7 December 2022 | | EYE - General, EYE - Cornea, EYE - Cataract, EYE - Glaucoma
It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...

International Women’s Day 2025: In Conversation With Dr Michelle Le Cheminant

9 March 2025 | international womans day, conversation, Q&A, ophthalmology, gender
Women make up 70% of the global health and social workforce but hold only 25% of leadership roles. In ophthalmology, women represent just 25-30% of ophthalmologists. Research shows that hospitals with increased female surgeons and anesthetists have lower odds of...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Clinical and management strategies in glaucoma practice: perspectives from international glaucoma specialists

1 April 2015 | | EYE - Glaucoma
Management options and outcomes in glaucoma practice were reviewed at the 7th Moorfields International Glaucoma Symposium, held in London on 24 January 2015. This article summarises perspectives from international glaucoma specialists on debated issues in topical therapy, glaucoma surgery, diagnostic...

Uveal melanoma

3 August 2023 | | EYE - Pathology, EYE - Oncology, EYE - Imaging
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...

The results of the last survey Dec23

4 December 2023 | | EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. Hopefully by...

Understanding amniotic membrane grafts

1 June 2019 | | EYE - Cornea, EYE - General
Safa Elhassan gives a brief review of amniotic membrane grafts and their application in theatre and clinic-based settings. Amniotic membrane (AM) transplant has been an established adjuvant treatment for many corneal, conjunctival and scleral disorders in ophthalmic clinical practice with...

Chronic dacryocystitis?

1 February 2018 | | EYE - General
Lacrimal drainage system tumours are rare and lymphomas account for less than 10% of these tumours [1]. Most patients presenting with lymphoma infiltration of the lacrimal drainage system have a history of previously diagnosed lymphoma elsewhere. We report a case...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...